Assessment of
EGFR
gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
Arch Med Sci
.
2019 Nov 3;16(6):1496-1500.
doi: 10.5114/aoms.2019.89217.
eCollection 2020.
Authors
Marcin Nicoś
1
2
,
Kamila Wojas-Krawczyk
1
3
,
Paweł Krawczyk
1
4
,
Izabela Chmielewska
1
,
Magdalena Wojcik-Superczyńska
1
,
Katarzyna Reszka
3
5
,
Robert Kieszko
1
,
Anna Góra-Florek
6
,
Małgorzata Dudek
6
,
Daria Świniuch
7
,
Wojciech Papiewski
8
,
Paulina Całka
9
,
Marzanna Ciesielka
9
,
Rodryg Ramlau
7
,
Janusz Milanowski
1
Affiliations
1
Department of Pneumonology, Oncology and Allergology, Medical University of Lublin, Lublin, Poland.
2
Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
3
Lublin Foundation for Cancer Patients "JestemnaTak", Poland.
4
Polish Society of Clinical Oncology, Warsaw, Poland.
5
GENIM LCC, Institute of Genetics and Immunology, Lublin, Poland.
6
Independent Public Provincial Hospital named Jan Boży, Lublin, Poland.
7
Department of Oncology, Poznan University of Medical Science, Poznan, Poland.
8
Department of Pulmonology and Pulmonary Oncology of Mazovian Specialist Hospital, Radom, Poland.
9
Department of Forensic Medicine, Medical University of Lublin, Lublin, Poland.
PMID:
33224359
PMCID:
PMC7667428
DOI:
10.5114/aoms.2019.89217
No abstract available